Spine Review Archives - Page 20 of 246 - Becker’s Spine Review

FDA clears 1st multi-arm spine robot | NuVasive infringed spine surgeon's patents, jury rules | Spine at a crossroads | Neuralink seeks $500M | Spine biologic gets IDE approval

April 24, 2025 BHR Newsletter 1. Spine at a crossroads: Lower cost, higher value in the ASC era Full story 2. Elon Musk's Neuralink seeks $500M in funding: Report Full story 3. What another practice's layoffs mean for Southeast Orthopedic…

Medtronic, FDA sued over spinal cord stimulator | Prominent neurosurgeon dies | A 'stay tuned' moment in spine | Top ASC operators by market share | Calif. spine group joins health system

April 23, 2025 BHR Newsletter 1. Spine medtech's 'stay tuned' moment Full story 2. Top 5 ASC operators by market share | 2025 Full story 3. Carolina Neurosurgery & Spine Associates founding partner dies Full story 4. Costs matter. Learn how…

6 states where spine surgeons thrive | Digital spine tool saves $1,712 per patient: Study | 4 top-paid spine tech CFOs | ASCs up their game | AR spine system hits 10K cases

April 22, 2025 BHR Newsletter 1. The states where spine surgeons thrive Full story 2. What's upping ASCs' game in 2025? Full story 3. Aclarion's digital spine tool saves $1,712 per patient: Study Full story 4. Orthopedics' biggest headwinds, growth strategies…

ACA's 'unintended' spine consequences | Zimmer Biomet acquires orthopedic co. | Consolidation's impact on spine care | Where physicians are investing | Alphatec launches spine system

April 21, 2025 BHR Newsletter 1. ACA's 'unintended consequences' are hurting spine care: Dr. Daniel Choi Full story 2. How spine care will be affected by consolidation Full story 3. Zimmer Biomet acquires Paragon 28 Full story 4. High costs…

Spine in 2035: What's coming? | Neuralink competitor gets FDA nod | Orthopedic pay vs. inflation | Alphatec's top-paid execs: 2024 | A 45-minute class bolstering spine care | Spinal implants' 'future is now'

April 18, 2025 BHR Newsletter 1. Neuralink competitor snags FDA approval Full story 2. Is orthopedic surgeon pay outpacing inflation? Full story 3. What spine will look like in 10 years Full story 4. Maximize your ASC's efficiency and growth potential…

Spine's overlooked trends | HHS faces 30% budget cut | Orthopedic pay in 2025: 4 notes | Why surgeons are optimistic about spine's future | TOA breaks ground on 23rd clinic

April 17, 2025 BHR Newsletter 1. The spine trends surgeons feel are being overlooked Full story 2. How orthopedic pay stacks up in 2025 Full story 3. White House eyes 30% HHS budget cut: 7 things to know Full story…

CMS changes spine surgeons want most | Spine's best ideas | Where FTC's noncompete ban stands | LDR sees more post-op facet injections than ALIFs: Study | 4 orthopedic MSO moves

April 16, 2025 BHR Newsletter 1. The CMS changes spine surgeons want now Full story 2. Here's where spine's best ideas are coming from today Full story 3. Where the FTC noncompete ban stands Full story 4. From budgeting to…

Spine robots won't stay a 'one-trick pony' | NY spine leader dies in plane crash | The outpatient race: Where spine stands | 8 spine, orthopedic studies to know | Wyo. hospital adds TOPS spine device

April 15, 2025 BHR Newsletter 1. Spine robots won't remain a 'one-trick pony' Full story 2. The race to outpatient: Where spine and 2 other specialties stand Full story 3. Spine community remembers Dr. Michael Groff Full story 4. High costs…

Orthopedic pay drops 3% | Congress cuts spinal cord injury research | Pfizer discontinues GLP-1 pill | DISC ASC partners with hospital | 8 spine, orthopedic medtech notes

April 14, 2025 BHR Newsletter 1. Orthopedist pay drops 3%, still highest specialty: Mesdcape Full story 2. Pfizer discontinues GLP-1 weight loss drug Full story 3. Congress cuts $40M+ for spinal research Full story 4. Not all AI tools deliver.…

Spine group's $24M noncompete win faces appeal | Dr. Oz's vision for CMS | Spine co. taps Keith Valentine as CEO | Orthopedic surgeon pay: 5 notes | OrthoIndy debuts AI spine tech

April 11, 2025 BHR Newsletter 1. Spine group's $24M noncompete verdict to be appealed Full story 2. Dr. Oz outlines vision for CMS: 8 notes Full story 3. Spine company names Keith Valentine CEO Full story 4. FDA approval isn't…